CIPLA Share Price, Analysis & Fundamentals

Cipla's Goa plant received VAI status from USFDA, a neutral development, while significant QoQ and YoY profit declines overshadow analyst optimism and a stable dividend.

Cipla's Goa manufacturing facility has received Voluntary Action Indicated (VAI) status from the USFDA following an April inspection, a positive development that suggests the facility's observations are being addressed proactively.
The company recently declared a final dividend of ₹13 per equity share for the fiscal year ending March 31, 2026, and also completed an allotment of ESOP/ESPS, indicating ongoing corporate actions and shareholder returns.
Fundamental analysis reveals a challenging quarter for the company, with revenue declining by 7.535% and net profit by 19.436% quarter-over-quarter, alongside a significant year-over-year drop in net profit of 55.272%.
Analyst sentiment remains largely bullish, with 59.46% of analysts recommending a 'Buy' or 'Strong Buy', although a notable 24.32% maintain a 'Hold' rating, suggesting a mixed but predominantly positive outlook.
Institutional investors, including FIIs and DIIs, collectively hold a significant 54.26% stake, with a recent shift observed as FIIs reduced their holdings by 1.38% while DIIs increased theirs by 1.26%.

The stock has shown positive short-term returns, with a 1-day return of 0.31% and a 1-month return of 6.89%.
The trend regime is neutral, with the price trading above the 50-day EMA but below the 9-day and 21-day EMAs, and is 2.14% above the 50-day moving average.
Momentum is neutral, indicated by an RSI of 52.67 and a bearish MACD signal.
Volatility is moderate, with the price positioned at 25.15% of the Bollinger Band width.
The stock is trading 16.87% below its 52-week high and 15.98% above its 52-week low, with a current drawdown of -16.87%.

The stock exhibits a neutral trend and momentum profile, with short-term positive returns. While the price is above key long-term moving averages, it is below shorter-term EMAs, suggesting a lack of strong upward momentum. The RSI is in neutral territory, and the MACD indicates bearishness. The stock is positioned within its 52-week range, neither extremely overbought nor oversold, but it is experiencing a notable drawdown from its peak. Volume signals do not indicate strong conviction at this time.

Revenue for Mar 2026 quarter was ₹6,541 Cr.
Quarter-over-Quarter (QoQ) performance shows a decrease in revenue by -7.535%, net profit by -19.436%, and EPS by -17.921%.
Year-over-Year (YoY) performance indicates a revenue decline of -2.808% and a significant drop in net profit by -55.272% and EPS by -54.594%.
Profitability has declined both QoQ and YoY, with Profit Before Tax decreasing by -20.829% QoQ and -52.992% YoY.

The company declared a final dividend of ₹13 per equity share for the fiscal year ending March 31, 2026. Additionally, an allotment of ESOP/ESPS was made in compliance with SEBI regulations.